Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.

Condition: HER2 Positive Breast Cancer
Journal: Current oncology (Toronto, Ont.)
Treatment Used: Neoadjuvant Pertuzumab
Number of Patients: 0
Published: December 22, 2022

Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis.

Condition: HER2 Positive Breast Cancer (BC)
Journal: Systematic reviews
Treatment Used: Lapatinib vs. Lapatinib plus Trastuzumab vs. Trastuzumab
Number of Patients: 0
Published: December 10, 2022

Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.

Condition: Women with HER2-Positive Breast Cancer
Journal: Future oncology (London, England)
Treatment Used: Trastuzumab and Pertuzumab vs. Trastuzumab and Pertuzumab Plus Chemotherapy
Number of Patients: 376
Published: October 27, 2022

Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study.

Condition: HER2 Positive pT1a-b pN0 Breast Cancer
Journal: Medicine
Treatment Used: Adjuvant Therapy
Number of Patients: 168
Published: June 27, 2022

T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.

Condition: HER2 Positive Metastatic Breast Cancer (MBC)
Journal: BMC cancer
Treatment Used: T-DM1
Number of Patients: 0
Published: June 07, 2022

Systemic management of brain metastases in HER2+ breast cancer in 2022.

Condition: Brain Metastases (BrMs) in HER2+ Breast Cancer
Journal: Clinical advances in hematology & oncology : H&O
Treatment Used: Systemic Therapies
Number of Patients: 0
Published: May 17, 2022

A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis.

Condition: Stage I pT1aN0M0 HER2+ Breast Cancer
Journal: Cancer
Treatment Used: Local Therapy Alone vs. Local Plus Systemic Therapy
Number of Patients: 8948
Published: April 01, 2022

The Efficacy of Combined Use of Pertuzumab and Trastuzumab-Based Neoadjuvant Chemotherapy for HER2 Positive Breast Cancer.

Condition: HER2 Positive Breast Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Treatment Used: Pertuzumab and Trastuzumab-Based Chemotherapy
Number of Patients: 11
Published: January 20, 2022

Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer.

Condition: Women with Stage I HER2 Positive (HER2+) Breast Cancer
Journal: International journal of radiation oncology, biology, physics
Treatment Used: Radiation Therapy (RT)
Number of Patients: 497
Published: October 27, 2021

De-Escalation of Radiation Therapy in Patients with cT1-T2 (< 3 cm) N0 HER2+ Breast Cancer Treated With Neoadjuvant Systemic Therapy With Pathologic Complete Response at the Time of Breast Conserving Surgery.

Condition: cT1-T2 N0 HER2+ Breast Cancer
Journal: International journal of radiation oncology, biology, physics
Treatment Used: De-Escalation of Radiation Therapy
Number of Patients: 4842
Published: October 27, 2021

T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer.

Condition: HER2+ Breast Cancer-Related Brain Metastases (BrM)
Journal: International journal of radiation oncology, biology, physics
Treatment Used: Trastuzumab Emtansine (T-DM1)
Number of Patients: 67
Published: October 27, 2021

Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.

Condition: Locally Advanced HER2 Positive Breast Cancer
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Treatment Used: Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy
Number of Patients: 63
Published: September 26, 2021
Showing 1-12 of 33

Last Updated: 02/19/2023